Background/Aims: To investigate whether brown zona pellucida (ZP) of oocytes affects the outcome of fertilization, embryo quality and pregnancy rate in in vitro fertilization-embryo transfer (IVF-ET). Methods: Based on the ZP color of their oocytes, a total number of 703 patients dated from 2012 to 2014 were divided into a normal egg group (group A) and a brown oocyte group (group B), with 629 and 74 cases, respectively. Clinical characteristics, gonadotropin (Gn) days, Gn dosage, serum hormone levels on the day of human chorionic gonadotropin (HCG) injection, ZP thickness (ZPT) of the eggs, fertilization rate, rescue intracytoplasmic sperm injection (rICSI) rate, good-quality embryo rate and pregnancy rate were compared between the two groups. Results: No significant differences were found in the duration and the causes of infertility, and their basal level of endocrine hormone before IVF-ET between normal egg group and brown egg group. The level of serum hormone including estradiol, progesterone and luteinizing hormone on the day of HCG injection were again similar. Moreover, there were no differences in number of mature oocytes, oocyte fertilization rates and rICSI rates after IVF between the two groups. However, we observed that the ZPT of brown oocytes (group B) was higher than that of normal oocytes (group A). Moreover, the Gn dosage and FSH levels on the day of HCG injection were significantly higher in group B than in group A and the good-quality embryo rate and pregnancy rate in group B were lower than those in group A. Conclusion: Compared with normal eggs, oocytes with a brown ZP were found to have a higher ZPT, lower embryo quality and lower pregnancy rate, which might be due to a high Gn dosage injection and high serum FSH levels during IVT-ET cycles.
Introduction
Acquisition of high-quality embryos is very important for improving the clinical pregnancy rate in in vitro fertilization-embryo transfer (IVF-ET). The oocyte quality is one of the key factors affecting implantation and pregnancy rates in human assisted reproductive technology (ART). Currently, the morphological evaluation is the most objective method to assess the quality of oocyte, and morphological features of eggs are also being used to predict the potential of embryonic development [1] . Good quality MII oocytes are judged based on several features such as a clear perivitelline space with certain thickness, well-distributed cytoplasmic granular particles, as well as a complete first polar body and a pale-colored zona pellucida (ZP) [2] . Depending on the locations of abnormal morphologies, Oocyte morphological abnormalities can be divided into intra-cytoplasmic and extra-cytoplasmic abnormalities. Cytoplasmic abnormalities include an abnormal distribution of cytoplasmic granules, abnormalities of the smooth endoplasmic reticulum and a liquefied bubble. Extracytoplasmic abnormalities include an irregular oocyte shape, enlargement of the perivitelline space, fragments in the perivitelline space and abnormalities in oocyte membrane viscosity and the ZP color, shape or thickness.
No consensus has been reached about the effects of oocyte morphological anomalies on fertilization, embryo quality and pregnancy outcomes [3] . Some studies have shown that abnormal oocytes adversely affected fertilization, embryo quality and pregnancy outcomes [4] [5] [6] [7] : the pregnancy and implantation rates decline with the transfer of embryos developed from morphologically abnormal oocytes [8, 9] . In contrast, other studies have shown that oocytes with morphological abnormalities did not affect the fertilization outcome [10] [11] [12] and the developmental potential of an embryo cannot be predicted from its oocyte morphology unless the morphology is extremely abnormal [13] .
Maturation of the human follicle can be divided into four stages: the primordial follicle, the primary follicle, secondary follicle and mature follicle, regardless of in a natural cycle or stimulated ovulation cycle. Any anomalies during these steps can block development of follicular and cause morphological abnormalities in the oocyte. During the process of oocyte maturation, the ZP changes constantly. Under most circumstances, the ZP appears to be pale, while in some cases the ZP appears to be brown or black. Oocytes with this brown or black colored ZP are called brown oocyte. Whether the color of ZP affect the outcome of pregnancy remains unknown. Some reports showed that brown oocytes had no significant effect on pregnancy outcomes [14] , while others have suggested that a brown oocyte could be associated with a lower fertilization, implantation or pregnancy rate [15] .
The exact reasons for the ZP color change remain unknown. In this study, we collected data for all brown oocytes in the past two years (2012 -2014) from our IVF center in Hubei Province, China, and compared their clinical features, the use of chelating agents, and basal hormone and daily HCG hormone levels. We analyzed the potential reasons leading to the ZP color change and its influence on the fertilization rate, embryo quality and pregnancy rate.
Materials and Methods

Study population
A retrospective analysis of 703 patients who underwent IVF-ET cycles in the Reproductive Medicine Center, Renmin Hospital, Hubei University of Medicine from February 2012 to December 2014 was performed. These patients were aged 22-40 years and had infertility for 2-8 years, excluding male infertility. Of the 703 patients, 468 cases were due to tubal infertility, 153 ovulation failure, 32 endometriosis, 23 polycystic ovary syndrome (PCOS), 2 immune infertility, and 25 unexplained infertility. The patients were divided into two groups based on the ZP color of their oocytes, with 629 cases with normal colored oocytes in Group A (Fig. 2 , right panel), and 74 cases with brown oocytes in Group B (Fig. 2, left panel) . The oocytes appeared to be brown due to the brown color of the ZP, as shown in Fig. 3 , which shows a zygote that had a ZP separated from the oocyte cytoplasm. The study was approved by the Human Reproductive Medical Ethics Committee of Shiyan Renmin Hospital with written informed consent obtained from all subjects. 
Ovarian stimulation and follicle growth monitoring
The gonadotropin-releasing hormone (GnRH) long protocol was used for all patients [16] , with daily injections of 0.05 mg/day triptorelin beginning in the luteal phase of the last menstrual cycle, to downregulate the activity of pituitary gland. Gonal-F alone or with human menopausal gonadotropin (HMG) was used for ovarian stimulation. The follicle was monitored using ultrasound until it reached 16-18 mm in diameter and was then stopped using FSH and HMG. An intramuscular injection of 5000-10000 IU of human chorionic gonadotropin (HCG) was given in 36 hrs before retrieval of the follicles along with the oocyte through transvaginal ultrasonography.
Measurement of hormones concentration
Venous blood was drawn in the morning of the second day of the menstrual cycle of the controlled ovarian hyperstimulation (COH) cycle of the day of HCG administration. FSH, E2, P and LH were measured by the DXI800 automatic electrochemical luminescence immunoassay system. The Access ESTRADIOL 3340 kits were purchased from Beckman Coulter, Inc. (Chaska, USA).
Oocyte observation and fertilization assessment
All of the oocytes were fertilized by IVF and the quality of their oocytes were assessed by two professional embryologists. A capillary was used to mechanically strip granule cells around the oocyte. The color of oocytes were observed. Whether the second polar body had discharged after 4~6 hours of fertilization is also been observed. Oocytes with a brown ZP were considered as brown oocytes (Fig. 2, left  panel) . Fertilization was only considered to be successful when all of the oocytes were observed to have extruded their second polar body. Otherwise, a rescue intracytoplasmic sperm injection (rICSI) procedure was subsequently performed and the fertilization outcome was judged base on the appearance of pronucleus after 16-18 hrs. If the two pronuclear stage appeared, we re-considered the fertilization to be successful.
Embryo transfer technique
The procedure of embryo transfer was performed as following. Firstly, a 1 ml syringe was connected to the embryo transfer catheter. Then, we transferred the embryos in turn, as follows: 5 μl culture media, 5 μl air, 8-10 μl culture media containing the embryos, 5 μl air, 5 μl culture media. Finally, we delivered the embryos into the uterus. In this procedure, the embryologist must check carefully and ensure that no embryo is left in the tube under the microscope.
Embryo culture and pregnancy assessment
Following fertilization by IVF or ICSI, the zygotes were transferred to the embryo culture media for 24 -48 hrs. The embryo morphological grading was performed on day 3 after ovum pick-up (OPU) [17] . Embryos with a magnitude of III or above were viable. Embryos with good morphology such as homogeneously distributed blastomeres and less fragments were usually preferred for transfer. We transplanted 2-3 embryos using ultrasound-guided embryo intrauterine transfer based on patient's age. After fourteen days of the embryo transplantation, the biochemical pregnancy could be detected and the clinical pregnancy is determined by successful detection of fetal heartbeat by ultrasound four weeks after embryo transfer.
Statistical Analysis
The data on concentrations of hormones and pregnancy rates were processed using SPSS 13.0 statistical software. Measurement data are described as the means ± sd, and differences between the groups were compared using the two-sided t test. The rates were compared using a Chi square test, where appropriate. Differences with P-values of < 0.05 were considered to be statistically significant.
Results
General comparison of patients in the brown oocyte group and the normal group
6742 oocytes, of which 5824 were mature, were collected from 703 patients and divided into two groups based on the color of oocytes. No significant differences were observed for the average age, body mass index (BMI), duration or causes of infertility between patients in the brown oocyte and normal groups (Table 1) . group and the normal group (Table 3) . However, the average ZP thickness of the brown oocyte group was higher than that of the normal group (P < 0.05), and the high-quality embryo and clinical pregnancy rates were lower than those of the normal group (P < 0.05).
Discussion
Compared with normal oocytes, the ZP of the brown oocytes showed abnormal color changes and were a translucent brown color in our study. There are few reports on the causes of or the mechanisms for the formation of brown oocytes. Our study suggests that the possible cause of the formation of oocytes with a brown ZP is not related to the average age of the infertile patients or to the cause and duration of infertility. Previous studies have shown no significant correlation between color of oocytes and the clinical outcome of pregnancy but have suggested that brown oocytes could be caused by ovarian stimulation [18] .
Exogenous FSH is commonly used to accelerate the maturation of follicles in order to obtain sufficient amount of oocytes in IVF cycles, in which the high-quality embryos can be selected after IVT for transfer. Exogenous FSH may affect the differentiation and growth of granulosa cells as well as the development of ovarian follicles. The appropriate FSH dosage does not affect gene expression of oocytes and granular cells significantly. However, a high FSH dosage will alter pattern of gene expression in antral follicular and granular cells, which usually results in disfunction of granular cell and abnormal oocyte development. Studies have shown that a high dose of exogenous hormones, especially FSH administrated in IVF-ET cycles, induce the morphologically abnormality of oocytes, including abnormalities in the ZP, cytoplasm and polar body [19] . Min Li et al. showed that the effect of exogenous FSH on oocytes and embryos is dependent on its concentration and that high-dose FSH reduced the quality of oocytes and embryos [20] .
In this study, most granulosa cells of brown oocytes were well scattered but were dark and aggregated (Fig. 1) , indicating that the granulosa cells may have been premature. ZP is mainly composed of glycoproteins (ZP1, ZP2 and ZP3 in mice), which are secreted by oocytes and granulosa cells. By knocking out ZP glycoprotein gene ZP1 in mice embryonic stem cells, Rankin found that the ZP structure of their oocytes was looser with enlarged perivitelline space [21] . In addition, targeted mutagenesis of ZP1 also resulted in heterogeneous distribution of granulosa cells around the oocyte, and incomplete ZP matrix. These changes suggested abnormal synthesis or secretion of the ZP protein from granulosa cells [22] . In our results, the occurrence of brown ZP correlate with a high dosage of exogenous FSH, indicating that the high dosage of exogenous FSH might lead to the brown ZP. It is possible that the high dosage of exogenous FSH continuously enters into the follicular fluid, leading to the abnormal synthesis and secretion of ZP protein from granulosa cells. Ultimately, this leads to the premature granular cells, with excessively dispersed or agglutinated appearance.
As shown in Table 3 , the number of high-quality embryos and pregnancy rate of the brown oocyte group were significantly lower than those of the normal oocyte group, which indicated that brown oocytes affected embryo development. In our study, clinical pregnancy was defined as the presence of an intrauterine gestational sac on the trans-vaginal ultrasound examination. We did not measure AMH concentrations [23] [24] [25] .
Most of the brown oocytes have a thicker ZP which appear darker than normal ones. ZP thickness in individual preembryos has been proposed to be a marker of normal human preembryo development because a correlation was observed between ZP thickness and implantation of thawed as well as fresh preembryos [26, 27] . A thinner portion of the zona pellucida is very likely necessary for appropriate hatching during the blastocyst stage. Thicker ZP preembryos reduced the implantation potential during hatching, and as a result, the high-quality embryo rate and clinical pregnancy rate are lower. We have incomplete data regarding live birth. 
